Mouse mutagenesis and disease models for neuropsychiatric disorders.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current topics in behavioral neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/7854_2010_106PMID 21298381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Temperature Gradient Capillary Electrophoresis for Detection of the Factor V Leiden Mutation

  2012cited by this paper
• Molecular genetic models related to schizophrenia and psychotic illness: heuristics and challenges.

  2011cited by this paper
• Animal models of depression: molecular perspectives.

  2011cited by this paper
• Cognitive remediation therapy for eating disorders: development, refinement and future directions.

  2011cited by this paper
• Animal models of epigenetic regulation in neuropsychiatric disorders.

  2011cited by this paper
• Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases

  2010cited by this paper
• Probing the biology of Alzheimer's disease in mice.

  2010cited by this paper
• Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update

  2010cited by this paper
• Embryonic Stem Cell-Derived Glial Precursors as a Vehicle for Sulfamidase Production in the MPS-IIIA Mouse Brain

  2010cited by this paper
• SGSH gene transfer in mucopolysaccharidosis type IIIA mice using canine adenovirus vectors.

  2010cited by this paper
• LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.

  2010cited by this paper
• Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.

  2010cited by this paper
• Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol.

  2009cited by this paper
• Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.

  2009influential reference
• R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice

  2009cited by this paper
• Intracranial gene delivery of LV‐NAGLU vector corrects neuropathology in murine MPS IIIB

  2009cited by this paper
• Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression

  2009cited by this paper
• The Genetic Signatures of Noncoding RNAs

  2009cited by this paper
• Examination of intravenous and intra‐CSF protein delivery for treatment of neurological disease

  2009cited by this paper
• Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.

  2009cited by this paper
• Next-generation gene targeting in the mouse for functional genomics.

  2009cited by this paper
• Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease

  2009cited by this paper
• IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice.

  2009cited by this paper
• Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.

  2008cited by this paper
• N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.

  2008cited by this paper
• Animal models of Alzheimer's disease and frontotemporal dementia

  2008cited by this paper
• Effect of high dose, repeated intra‐cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice

  2008cited by this paper
• Trends in large-scale mouse mutagenesis: from genetics to functional genomics

  2008cited by this paper
• A Drosophila model for LRRK2-linked parkinsonism

  2008cited by this paper
• Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

  2008influential reference
• Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium

  2008cited by this paper
• Psychiatric genetics: progress amid controversy

  2008cited by this paper
• Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration

  2007cited by this paper
• Behavioral phenotypes of Disc1 missense mutations in mice.

  2007cited by this paper
• Primary episodic ataxias: diagnosis, pathogenesis and treatment.

  2007cited by this paper
• Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease

  2007cited by this paper
• A genetic variant of the serine racemase gene is associated with schizophrenia.

  2007cited by this paper
• Neuronal !-Synucleinopathy with Severe Movement Disorder in Mice Expressing A 53 T Human !-Synuclein

  2007cited by this paper
• Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans

  2007influential reference
• New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy

  2007cited by this paper
• A mouse for all reasons.

  2007cited by this paper
• Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice

  2007cited by this paper
• Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.

  2007cited by this paper
• A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).

  2006cited by this paper
• A decade of modeling Alzheimer's disease in transgenic mice.

  2006cited by this paper
• The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype.

  2006cited by this paper
• Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice.

  2006influential reference
• Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.

  2006cited by this paper
• Disrupted in schizophrenia 1: building brains and memories.

  2006cited by this paper
• Inhibition of Glycosaminoglycan Synthesis Using Rhodamine B in a Mouse Model of Mucopolysaccharidosis Type IIIA

  2006cited by this paper
• Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

  2006cited by this paper
• Glutamine-Expanded Ataxin-7 Alters TFTC/STAGA Recruitment and Chromatin Structure Leading to Photoreceptor Dysfunction

  2006cited by this paper
• Deletion Polymorphism of Disc1 Is Common to All 129 Mouse Substrains: Implications for Gene-Targeting Studies of Brain Function

  2006cited by this paper
• D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.

  2005cited by this paper
• DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

  2005cited by this paper
• Molecular characterization of ENU mouse mutagenesis and archives.

  2005cited by this paper
• Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).

  2005cited by this paper
• A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development

  2005cited by this paper
• Age-dependent dopaminergic dysfunction in Nurr1 knockout mice.

  2005cited by this paper
• Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice Published, JLR Papers in Press, February 1, 2005. DOI 10.1194/jlr.M400411-JLR200

  2005cited by this paper
• [International HapMap project].

  2005cited by this paper
• The Knockout Mouse Project

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.

  2004cited by this paper
• A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.

  2004cited by this paper
• Improved Behavior and Neuropathology in the Mouse Model of Sanfilippo Type IIIB Disease after Adeno-Associated Virus-Mediated Gene Transfer in the Striatum

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder

  2004cited by this paper
• Erratum: Corrigendum: The European dimension for the mouse genome mutagenesis program

  2004cited by this paper
• Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.

  2003cited by this paper
• The LightTyper: high-throughput genotyping using fluorescent melting curve analysis.

  2003cited by this paper
• Chemical chaperone therapy for brain pathology in GM1-gangliosidosis

  2003cited by this paper
• High-resolution genotyping by amplicon melting analysis using LCGreen.

  2003cited by this paper
• Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer

  2003cited by this paper
• A mouse model of episodic ataxia type-1

  2003cited by this paper
• Large-scale discovery of induced point mutations with high-throughput TILLING.

  2003cited by this paper
• Mutations in NR4A2 associated with familial Parkinson disease

  2003cited by this paper
• Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.

  2003cited by this paper
• Purkinje cell degeneration (pcd) Phenotypes Caused by Mutations in the Axotomy-Induced Gene, Nna1

  2002cited by this paper
• Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1).

  2002cited by this paper
• Initial sequencing and comparative analysis of the mouse genome.

  2002cited by this paper
• A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

  2002cited by this paper
• Integrated platform for detection of DNA sequence variants using capillary array electrophoresis

  2002cited by this paper
• Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia

  2002cited by this paper
• Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report

  2002cited by this paper
• Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.

  2001cited by this paper
• SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice.

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Critical role for glycosphingolipids in Niemann-Pick disease type C.

  2001cited by this paper
• Engineering chromosomal rearrangements in mice

  2001cited by this paper
• Advances in schizophrenia

  2001cited by this paper
• Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.

  2001cited by this paper
• Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695*

  2001cited by this paper
• A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant.

  2001cited by this paper
• High-throughput detection of unknown mutations by using multiplexed capillary electrophoresis with poly(vinylpyrrolidone) solution.

  2000cited by this paper
• The mutagenic action of N-ethyl-N-nitrosourea in the mouse

  2000cited by this paper
• Search for schizophrenia susceptibility genes.

  2000cited by this paper
• Disruption of two novel genes by a translocation co-segregating with schizophrenia.

  2000cited by this paper
• D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.

  2000cited by this paper
• Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission.

  1999cited by this paper

• Mouse Models for Human Diseases by Forward and Reverse Genetics

  2013cites this paper
• Animal Models of Psychiatric Disorders That Reflect Human Copy Number Variation

  2012cites this paper
• Mouse models of autism: testing hypotheses about molecular mechanisms.

  2011cites this paper
• Animal models of depression: molecular perspectives.

  2011cites this paper
• Molecular genetic models related to schizophrenia and psychotic illness: heuristics and challenges.

  2011cites this paper
• When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience.

  2011cites this paper
• Transgenic Animal Models of Huntington's Disease.

  2011cites this paper
• Drosophila as a model organism for the study of neuropsychiatric disorders.

  2011cites this paper
• Towards artificial metallonucleases for gene therapy: recent advances and new perspectives.

  2011cites this paper